IP Library › Granted Patent US 12,749,180
Granted Patent B2
US 12,749,180 · App. 18/110,535 · Granted Sep 29, 2026

Systems and methods for the automated detection of cerebral microbleeds using 3T MRI

Inventors: Adam M. Brickman (Ardsley, NY); Anthony G. Chesebro (Port Jefferson, NY)
Assignee: The Trustees of Columbia University in the City of New York
G06T7/0012G06T7/13G06T7/136G06T7/168G06T7/337G06T7/74G06V10/25G06T2207/10088G06T2207/20061G06T2207/20221G06T2207/30016G06T2207/30104
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,749,180
App. No.
18/110,535
Granted
Sep 29, 2026
Kind
B2
Abstract

Automated cerebral microbleed detection is performed in extracted T2*-weighted image data, including gradient echo (GRE) image data and susceptibility-weighted imaging (SWI) image data. The image data is resampled and potential 2D regions of interest (ROI) having a circular or ellipsoidal shape are identified based in part on a respective intensity of associated resampled image pixels. The number of 2D ROIs are reduced by size, edge, and/or cerebrospinal fluid (CSF) mask exclusion, and then merged to form 3D ROIs. False positive 3D ROIs are removed and the remaining ROIs stored for review by a trained rater. The embodiments of the present disclosure outperform visual ratings of cerebral microbleeds, reducing the time to visually rate the scans while retaining sensitivity to the microbleeds themselves. These embodiments also exhibit higher sensitivity in longitudinal identification of microbleed locations, and are suited to longitudinal examination of cerebrovascular disease, e.g., Alzheimer's in adults with Down syndrome.

Claims (52)

1 . A method for cerebral microbleed detection, the method comprising:

acquiring, by a preprocessor module, magnetic resonance imaging (MRI) image data, the MRI image data comprising T1-weighted MRI image data and acquired T2*-weighted image data;

extracting, by the preprocessor module, extracted T2*-weighted image data from the acquired T2*-weighted image data, the extracted T2*-weighted image data corresponding to gradient echo (GRE) image data or susceptibility-weighted imaging (SWI) image data;

resampling, by the preprocessor module, the extracted T2*-weighted image data to a relatively higher resolution to yield resampled image data, the resampled image data comprising a plurality of slices;

identifying, by a detection module, each potential microbleed location in each slice of the resampled image data based, at least in part, on a respective intensity of each of a plurality of resampled image pixels, each potential microbleed location corresponding to a potential region of interest (ROI) and having a circular or ellipsoidal shape to within a shape tolerance;

reducing, by the detection module, a number of potential ROIs based, at least in part on at least one reduction criterion to yield a reduced number of potential two-dimensional (2D) ROIs;

merging, by the detection module, the reduced number of 2D ROIs into at least one merged potential three dimensional (3D) ROI, the merging performed between a plurality of adjacent slices;

defining, by the detection module, a standardized potential 3D ROI for each merged potential 3D ROI, each standardized potential 3D ROI having a respective 3D center and a surrounding neighborhood having a common size;

removing, by a 3D geometric filtering module, each potential false positive 3D ROI from the at least one standardized potential 3D ROI based, at least in part, on at least one 3D ROI characteristic of each standardized potential 3D ROI, to yield a number of final potential 3D ROIs; and

storing, by a final module, each of the final potential 3D ROIs comprising a location and a volume, associated with the extracted T2*-weighted image data, for review by a trained rater.

2 . The method of claim 1 , further comprising:

co-registering, by the preprocessor module, the T1-weighted MRI image data and an atlas-based lobar mask to the resampled image data to generate co-registered image data; and

determining, by the preprocessor module, a cerebrospinal fluid (CSF) mask based, at least in part, on a co-registered T1-weighted image data.

3 . The method of claim 1 , wherein the identifying each potential microbleed location comprises determining a 2D image gradient, detecting each edge pixel, applying hysteresis thresholding, and detecting each potential ROI having the circular or ellipsoidal shape.

4 . The method of claim 3 , wherein determining the 2D image gradient is performed using a Sobel filter, each edge pixel is detected using Canny edge detection, and each potential ROI having the circular or ellipsoidal shape is detected using a Hough transform.

5 . The method of claim 1 , wherein the at least one reduction criterion includes discarding each potential ROI positioned on an edge of an image, merging a plurality of overlapping ROIs, excluding each ROI having a size greater than a threshold size, excluding each singular ROI, and excluding each ROI that overlaps a cerebrospinal fluid (CSF) mask.

6 . The method of claim 1 , wherein removing each potential false positive 3D ROI from the at least one standardized potential 3D ROI comprises determining a vesselness of all voxels contained within each standardized potential 3D ROI.

7 . The method of claim 1 , wherein the 3D ROI characteristic includes a 3D image entropy of a selected standardized potential 3D ROI, a 2D image entropy of a maximum intensity projection of the selected standardized potential 3D ROI, a volume of a central blob of the selected standardized potential 3D ROI, a compactness of the central blob of the selected standardized potential 3D ROI, or combinations thereof.

8 . The method of claim 7 , wherein the volume and compactness of the central blob are determined based, at least in part, on Frangi filtering.

9 . The method of claim 1 , further comprising determining, by the final module, a number of identified microbleeds, and generating, by the final module, a distribution of locations using a co-registered lobar mask.

10 . A system for cerebral microbleed detection, the system comprising:

a computing device comprising a processor, a memory, input/output circuitry, and a data store;

a preprocessor module configured to acquire magnetic resonance imaging (MRI) image data, the MRI image data comprising T1-weighted MRI image data and acquired T2*-weighted image data;

the preprocessor module further configured to extract extracted T2*-weighted image data from the acquired T2*-weighted image data, the extracted T2*-weighted image data corresponding to gradient echo (GRE) image data or susceptibility-weighted imaging (SWI) image data;

the preprocessor module further configured to resample the extracted T2*-weighted image data to a relatively higher resolution to yield resampled image data, the resampled image data comprising a plurality of slices;

a detection module configured to identify each potential microbleed location in each slice of the resampled image data based, at least in part, on a respective intensity of each of a plurality of resampled image pixels, each potential microbleed location corresponding to a potential region of interest (ROI) and having a circular or ellipsoidal shape to within a shape tolerance;

the detection module further configured to reduce a number of potential ROIs based, at least in part on at least one reduction criterion to yield a reduced number of potential two-dimensional (2D) ROIs;

the detection module further configured to merge the reduced number of 2D ROIs into at least one merged potential three dimensional (3D) ROI, the merging performed between a plurality of adjacent slices;

the detection module further configured to define a standardized potential 3D ROI for each merged potential 3D ROI, each standardized potential 3D ROI having a respective 3D center and a surrounding neighborhood having a common size;

a 3D geometric filtering module configured to remove each potential false positive 3D ROI from the at least one standardized potential 3D ROI based, at least in part, on at least one 3D ROI characteristic of each standardized potential 3D ROI, to yield a number of final potential 3D ROIs; and

a final module configured to store each of the final potential 3D ROIs comprising a location and a volume, associated with the extracted T2*-weighted image data, for review by a trained rater.

11 . The system of claim 10 , wherein the preprocessor module is configured to co-register the T1-weighted MRI image data and an atlas-based lobar mask to the resampled image data to generate co-registered image data; and to determine a cerebrospinal fluid (CSF) mask based, at least in part, on a co-registered T1-weighted image data.

12 . The system of claim 10 , wherein removing each potential false positive 3D ROI from the at least one standardized potential 3D ROI comprises determining a vesselness of all voxels contained within each standardized potential 3D ROI.

13 . The system of claim 10 , wherein the 3D ROI characteristic includes a 3D image entropy of a selected standardized potential 3D ROI, a 2D image entropy of a maximum intensity projection of the selected standardized potential 3D ROI, a volume of a central blob of the selected standardized potential 3D ROI, a compactness of the central blob of the selected standardized potential 3D ROI, or combinations thereof.

14 . The system of claim 10 , wherein the final module is configured to determine a number of identified microbleeds, and to generate a distribution of locations using a co-registered lobar mask.

15 . A computer readable storage device having stored thereon instructions that when executed by one or more processors result in the following operations comprising:

acquiring magnetic resonance imaging (MRI) image data, the MRI image data comprising T1-weighted MRI image data and acquired T2*-weighted image data;

extracting extracted T2*-weighted image data from the acquired T2*-weighted image data, the extracted T2*-weighted image data corresponding to gradient echo (GRE) image data or susceptibility-weighted imaging (SWI) image data;

resampling the extracted T2*-weighted image data to a relatively higher resolution to yield resampled image data, the resampled image data comprising a plurality of slices;

identifying each potential microbleed location in each slice of the resampled image data based, at least in part, on a respective intensity of each of a plurality of resampled image pixels, each potential microbleed location corresponding to a potential region of interest (ROI) and having a circular or ellipsoidal shape to within a shape tolerance;

reducing a number of potential ROIs based, at least in part on at least one reduction criterion to yield a reduced number of potential two-dimensional (2D) ROIs;

merging the reduced number of 2D ROIs into at least one merged potential three dimensional (3D) ROI, the merging performed between a plurality of adjacent slices;

defining a standardized potential 3D ROI for each merged potential 3D ROI, each standardized potential 3D ROI having a respective 3D center and a surrounding neighborhood having a common size;

removing each potential false positive 3D ROI from the at least one standardized potential 3D ROI based, at least in part, on at least one 3D ROI characteristic of each standardized potential 3D ROI, to yield a number of final potential 3D ROIs; and

storing each of the final potential 3D ROIs comprising a location and a volume, associated with the extracted T2*-weighted image data, for review by a trained rater.

16 . The device of claim 15 , wherein the instructions stored thereon that when executed by one or more processors result in the following operations comprising:

co-registering the T1-weighted MRI image data and an atlas-based lobar mask to the resampled image data to generate co-registered image data; and

determining a cerebrospinal fluid (CSF) mask based, at least in part, on a co-registered T1-weighted image data.

17 . The device of claim 15 , wherein the at least one reduction criterion includes discarding each potential ROI positioned on an edge of an image, merging a plurality of overlapping ROIs, excluding each ROI having a size greater than a threshold size, excluding each singular ROI, and excluding each ROI that overlaps a cerebrospinal fluid (CSF) mask.

18 . The device of claim 15 , wherein removing each potential false positive 3D ROI from the at least one standardized potential 3D ROI comprises determining a vesselness of all voxels contained within each standardized potential 3D ROI.

19 . The device of claim 15 , wherein the 3D ROI characteristic includes a 3D image entropy of a selected standardized potential 3D ROI, a 2D image entropy of a maximum intensity projection of the selected standardized potential 3D ROI, a volume of a central blob of the selected standardized potential 3D ROI, a compactness of the central blob of the selected standardized potential 3D ROI, or combinations thereof.

20 . The device of claim 15 , wherein the instructions stored thereon that when executed by one or more processors result in the following operations comprising: determining a number of identified microbleeds; and generating a distribution of locations using a co-registered lobar mask.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2023
From: BRICKMAN, ADAM M.; CHESEBRO, ANTHONY G.
To: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
Reel/Frame 063092/0554 →
Continuity (2)
Provisional Application 63310767 · Feb 16, 2022
Related Publication 20230298170A1 · Sep 21, 2023
References Cited (25)
US 7660453B2 · Lang · 2010 [cited by examiner]
US 10275680B2 · Zach · 2019 [cited by examiner]
US 10410344B2 · Alsop · 2019 [cited by examiner]
US 11282193B2 · Harrison · 2022 [cited by examiner]
US 11430119B2 · Bhatia · 2022 [cited by examiner]
US 11461990B2 · Xiang · 2022 [cited by examiner]
US 11701024B2 · Shirai · 2023 [cited by examiner]
US 20150208994A1 · Rapoport · 2015 [cited by examiner]
US 20170258420A1 · Inglese · 2017 [cited by examiner]
US 20190012783A1 · Zahid · 2019 [cited by examiner]
US 20200005463A1 · Wu · 2020 [cited by examiner]
US 20200167930A1 · Wang · 2020 [cited by examiner]
US 20200272841A1 · Han · 2020 [cited by examiner]
US 20230281822A1 · Lee · 2023 [cited by examiner]
US 20230298170A1 · Brickman · 2023 [cited by examiner]
US 20240070857A1 · Zhang · 2024 [cited by examiner]
US 20240315655A1 · Siemionow · 2024 [cited by examiner]
Chesebro, A.G., Amarante, E., Lao, P.J. et al. Automated detection of cerebral microbleeds on T2-weighted MRI. Sci Rep 11, 4004 (2021). https://doi.org/10.1038/s41598-021-83607-0 (Year: 2021). [cited by examiner]
Park, SH., Lim, H., Bae, B.K. et al. Robustness of magnetic resonance radiomic features to pixel size resampling and interpolation in patients with cervical cancer. Cancer Imaging 21, 19 (2021). https://doi.org/10.1186/… [cited by examiner]
Kuijf, H.J., et al., “Semi-Automated Detection of Cerebral Microbleeds on 3.0 T MR Images,” PLoS One, vol. 8, Issue 6, pp. 1-6, Jun. 2013. [cited by applicant]
Zahid, A.B., et al., “Accelerated Brain Atrophy on Serial Computed Tomography: Potential Marker of the Progression of Alzheimer's Disease,” Journal of Computer Assisted Tomography, vol. 40, Issue 5, pp. 827-832, Sep. 20… [cited by applicant]
Dou, Q., et al., “Automatic Detection of Cerebral Microbleeds From MR Images via 3D Convolutional Neural Networks,” IEEE Transactions on Medical Imaging, vol. 35, Issue 5, pp. 1182-1195, May 2016. [cited by applicant]
Kamnitsas, K., et al., “Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation,” Medical Image Analysis, vol. 36, pp. 61-78, 2017. [cited by applicant]
Kuijf, H.J., et al., “Efficient detection of cerebral microbleeds on 7.0 T MR images using the radial symmetry transform,” NeuroImage, vol. 59, Issue 3, pp. 2266-2273, 2012. [cited by applicant]
Chen, H., et al., “VoxResNet: Deep voxelwiseresidual networks for brain segmentation from 3D MR images,” NeuroImage, vol. 170, pp. 446-455, 2018. [cited by applicant]